* A study of 41 CD patients at National Taiwan University Hospital over nearly two decades found an 82.9% initial remission rate after treatment, with follow-ups revealing significant changes in body mass index (BMI) and hormone levels.
* The research indicated that a greater decrease in BMI and lower dehydroepiandrosterone sulfate (DHEAS) levels before treatment are linked to remission, while higher adrenocorticotropic hormone (ACTH) levels before treatment can predict recurrence of the disease